Skip to main content

Table 2 The relationship between BOLA family members and OS in other different subtypes of OC (Kaplan-Meier plotter)

From: Expression profiles and prognostic values of BolA family members in ovarian cancer

Subtypes

BOLA1

BOLA2

BOLA3

Cases

HR (95% CI)

P value

Cases

HR (95% CI)

P value

Cases

HR (95% CI)

Pvalue

Histology

Serous

1207

0.93(0.8–1.08)

0.34

1207

0.86(0.73–1.01)

0.061

523

1.36(1.04–1.77)

0.022

Endometrioid

37

2.13(0.24–19.05)

0.49

37

4.42(0.74–26.51)

0.075

30

3.77(0.39–36.42)

0.22

Stage

1

74

2.29 (0.73–7.25)

0.15

74

0.43 (0.14–1.35)

0.14

51

2.52 (0.6–10.55)

0.19

2

61

0.52 (0.18–1.5)

0.22

61

0.28 (0.08–1.01)

0.038

32

0.16 (0.02–1.36)

0.057

3

1044

1.15 (0.97–1.36)

0.097

1044

1.15 (0.95–1.38)

0.15

426

1.38 (1.05–1.81)

0.019

4

176

1.38 (0.95–2.01)

0.087

176

0.69 (0.47–1.02)

0.059

61

0.49 (0.26–0.9)

0.019

Grade

1 + 2

380

1.54 (1.16–2.06)

0.003

380

0.79 (0.6–1.06)

0.11

203

1.54 (0.97–2.46)

0.064

3

1015

1.11 (0.92–1.34)

0.28

1015

0.82 (0.7–0.98)

0.025

392

0.73 (0.56–0.96)

0.022

TP53

Mutated

506

0.84 (0.65–1.08)

0.17

506

0.71 (0.56–0.89)

0.0025

124

0.79 (0.54–1.16)

0.23

WT

94

0.5 (0.29–0.89)

0.015

94

0.54 (0.25–1.14)

0.1

19

1.38 (0.49–3.92)

0.54

CR

Platin

1409

1.14 (0.99–1.32)

0.07

1409

0.94 (0.81–1.09)

0.41

478

1.30 (1–1.69)

0.047

Taxol

793

1.16 (0.95–1.4)

0.14

793

1.17 (0.97–1.41)

0.11

357

1.39 (1.01–1.93)

0.043

Taxol + platin

776

1.17 (0.97–1.43)

0.10

776

1.19 (0.98–1.44)

0.075

356

1.40(1.01–1.93)

0.041

  1. The bold font indicates the difference was significant statistically
  2. OC ovarian cancer, OS overall survival, WT wild type, CR Chemotherapy Regimen